Trial sequential analysis of randomized controlled trials on neoadjuvant therapy for resectable pancreatic cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,General Medicine,Surgery
Reference26 articles.
1. Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer;Versteijne;Br J Surg,2018
2. Neoadjuvant therapy followed by resection versus upfront resection for resectable pancreatic cancer: a propensity score matched analysis;Mokdad;J Clin Oncol,2017
3. Neoadjuvant therapy for resectable pancreatic cancer: a new standard of care. Pooled data from 3 randomized controlled trials;Birrer;Ann Surg,2021
4. Cochrane Handbook for systematic reviews of interventions;Higgins,2019
5. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis;Wetterslev;J Clin Epidemiol,2008
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer;JAMA Surgery;2024-07-24
2. Vitamin D and pancreatic cancer;Feldman and Pike's Vitamin D;2024
3. Alarming correlation between multidrug-resistant bacteriobilia and morbidity after pancreatic surgery;Digestive and Liver Disease;2023-11
4. Acute cholecystitis: Which flow-chart for the most appropriate management?;Digestive and Liver Disease;2023-09
5. Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer;Surgery;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3